Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 2, 2012, Pages 163-172

  Leung Ki, En Ling ^a   Chan, Francis K L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Helicobacter pylori; Low dose aspirin; Peptic ulcer; Peptic ulcer bleeding; Upper gastrointestinal bleeding; Upper gastrointestinal injury

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; THROMBOXANE A2;

ACHLORHYDRIA; APOPTOSIS; ARTICLE; ATROPHIC GASTRITIS; CELL PROLIFERATION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; ENZYME INHIBITION; ERADICATION THERAPY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LOW DRUG DOSE; MUCOSA CELL; PEPTIC ULCER BLEEDING; PROSTAGLANDIN SYNTHESIS; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH PH; THROMBOCYTOPOIESIS; UPPER GASTROINTESTINAL BLEEDING; UPPER GASTROINTESTINAL TRACT; UPREGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GASTRIC ACID; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; RECURRENCE; UPPER GASTROINTESTINAL TRACT;

EID: 84860233515     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.01.006     Document Type: Article

References (37)

1. A. Lanas, and J. Scheiman Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment Curr Med Res Opin 23 2007 163 173
2. C. Sostres, and A. Lanas Gastrointestinal effects of aspirin Nat Rev Gastroenterol Hepatol 8 2011 385 394
3. A. Lanas Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice Expert Opin Drug Saf 10 2011 45 54
4. F.K. Chan NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management Drug Saf 28 2005 287 300
5. F.K.L. Chan Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin? Chin J Dig Dis 6 2005 1 5
6. G.V. Papatheodoridis, and A.J. Archimandritis Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users World J Gastroenterol 11 2005 3811 3816
7. M. Venerito, and P. Malfertheiner Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers Helicobacter 15 2010 239 250
8. T. Brzozowski, P.C. Konturek, Z. Sliwowski, S. Kwiecień, D. Drozdowicz, and M. Pawlik Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals J Physiol Pharmacol 57 2006 67 79
9. F.K. Chan, S.C. Chung, B.Y. Suen, Y.T. Lee, W.K. Leung, and V.K. Leung Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 2001 967 973
10. K. Iijima, N. Ara, Y. Abe, T. Koike, W. Iwai, and K. Uno Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy J Gastroenterol 46 2011 612 619
11. C.J. Hawkey, Z. Tulassay, L. Szczepanski, C.J. van Rensburg, A. Filipowicz-Sosnowska, and A. Lanas Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study Lancet 352 1998 1016 1021
12. C.J. Hawkey, I. Wilson, J. Naesdal, G. Lngström, A.J. Swannell, and N.D. Yeomans Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users Gut 51 2002 344 350
13. J. Hart, C.J. Hawkey, A. Lanas, J. Naesdal, N.J. Talley, and A.B. Thomson Predictors of gastroduodenal erosions in patients taking low-dose aspirin Aliment Pharmacol Ther 31 2010 Jan 143 149
14. T. Hagiwara, K.I. Mukaisho, T. Nakayama, H. Sugihara, and T. Hattori Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori Gut 60 2011 624 630
15. F.K. Chan, J.J. Sung, R. Suen, Y.T. Lee, J.C. Wu, and W.K. Leung Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study Aliment Pharmacol Ther 12 1998 1201 1205
16. J.W. Konturek, A. Dembinski, S.J. Konturek, J. Stachura, and W. Domschke Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans Gastroenterology 114 1998 245 255
17. R. Pajdo, T. Brzozowski, P. Konturek, Z. Sliwowski, A. Ptak-Belowska, and G. Krzysiek-Maczka Effect of Helicobacter pylori infection on the phenomenon of gastric mucosal adaptation to repetitive aspirin insult in mongolian gerbils. Role of reactive oxygen metabolites and proinflammatory cytokines (abstr) Gastroenterology 138 2010 S244
18. E.H. Fletcher, D.E. Johnston, C.R. Fisher, R.J. Koerner, J.L. Newton, and C.S. Gray Systematic review: H. pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin Aliment Pharmacol Ther 32 2010 831 839
19. A. Lanas, J. Fuentes, R. Benito, P. Serrano, E. Bajador, and R. Sáinz Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin Aliment Pharmacol Ther 16 2002 779 786
20. W.A. Stack, J.C. Atherton, G.M. Hawkey, R.F. Logan, and C.J. Hawkey Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding Aliment Pharmacol Ther 16 2002 497 506
21. N.D. Yeoman, A.I. Lanas, N.J. Talley, A.B.R. Thmson, R. Daneshjoo, and B. Eriksson Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Aliment Pharmacol Ther 22 2005 795 801
22. K.C. Lai, S.K. Lam, K.M. Chu, B.C. Wong, W.M. Hui, and W.H. Hu Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use N Engl J Med 346 2002 2033 2038
23. F.K.L. Chan, J. Ching, B.Y. Suen, Y.K. Tse, J.C. Wu, and J.J. Sung Effect of Helicobacter pylori eradication on the long-term incidence of recurrent ulcer bleeding in high-tisk aspirin users: a 10-year prospective cohort study (abstr) Gastroenterology 140 2011 S173 S174
24. A. Giral, O. Ozdogan, C.A. Celikel, N. Tozun, N.B. Ulusoy, and C. Kalayci Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury J Gastroenterol Hepatol 19 2004 773 777
25. J.Q. Huang, S. Sridhar, and R.H. Hunr Rol of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis Lancet 359 2002 14 22
26. M. Vergara, M. Caralan, J.P. Gisbert, and X. Calvet Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users Aliment Pharmacol Ther 21 2005 1411 1418
27. T. Tanigawa, T. Watanabe, Y. Nadatani, K. Otani, H. Machida, and H. Okazaki Gastrointestinal bleeding after percutaneous coronary intervention Digestion 83 2011 153 160
28. A. Lanas, L.A. García-Rodríguez, M.T. Arroyo, L. Bujanda, F. Gomollón, and M. Forné Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants Am J Gastroenterol 102 2007 507 515
29. N.S. Abraham, M.A. Hlatky, E.M. Antman, D.L. Bhatt, D.J. Bjorkman, and C.B. Clark ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Am J Gastroenterol 105 2010 2533 2549
30. J.M. Scheiman, R.R. Bandekar, M.E. Chernew, and A.M. Fendrick Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis Aliment Pharmacol Ther 15 2001 63 71
31. G.I. Leontiadis, A. Sreedharan, S. Dorward, P. Barton, B. Delaney, and C.W. Howden Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding Health Technol Assess 11 2007 1 164
32. W.D. Chey, S. Eswaren, C.W. Howden, J.M. Inadomi, A.M. Fendrick, and J.M. Scheiman Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey Aliment Pharmacol Ther 23 2005 655 668
33. W.D. Chey, and B.C. Wong Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection Am J Gastroenterol 102 2007 1808 1825
34. P. Malfertheiner, F. Megraud, C. O'Morain, F. Bazzoli, E. El-Omar, and D. Graham Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 56 2007 772 781
35. M. Asaka, M. Kato, S. Takahashi, Y. Fukuda, T. Sugiyama, and H. Ota Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition Helicobacter 15 2010 1 20
36. D.L. Bhatt, J. Scheiman, N.S. Abraham, E.M. Antman, F.K. Chan, and C.D. Furberg ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Am J Gastroenterol 103 2008 2890 2907
37. F.L. Lanza, F.K. Chan, and E.M. Quigley Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 2009 728 738